» Articles » PMID: 22382249

Medication Prescribing Patterns Among Chronic Kidney Disease Patients in a Hospital in Malaysia

Overview
Date 2012 Mar 3
PMID 22382249
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

To determine the medication prescribing patterns in hospitalized patients with chronic kidney disease (CKD) in a Malaysian hospital, we prospectively studied a cohort of 600 patients in two phases with 300 patients in each phase. The first phase was carried out from the beginning of February to the end of May 2007, and the second phase was from the beginning of March to the end of June 2008. Patients with CKD who had an estimated creatinine clearance ≤ 50 mL/min and were older than 18 years were included. A data collection form was used to collect data from the patients' medical records and chart review. All systemic medications prescribed during hospitalization were included. The patients were prescribed 5795 medications. During the first phase, the patients were prescribed 2814 medication orders of 176 different medications. The prescriptions were 2981 of 158 medications during the second phase. The mean number of medications in the first and second phases was 9.38 ± 3.63 and 9.94 ± 3.78 respectively (P-value = 0.066). The top five used medications were calcium carbonate, folic acid/vitamin B complex, metoprolol, lovastatin, and ferrous sulfate. The most commonly used medication classes were mineral supplements, vitamins, antianemic preparations, antibacterials, and beta-blocking agents. This study provides an overview of prescription practice in a cohort of hospitalized CKD patients and indicates possible areas of improvement in prescription practice.

Citing Articles

Drug utilisation study in hospitalised chronic kidney disease patients, using World Health Organisation prescribing indicators: an observational study.

Alruqayb W, Paudyal V, Malcolm P, Sarwar A, Aston J, Cox A J Pharm Policy Pract. 2024; 17(1):2430436.

PMID: 39640417 PMC: 11619015. DOI: 10.1080/20523211.2024.2430436.


Nephrotoxic drug burden and predictors of exposure among patients with renal impairment in Ethiopia: A multi-center study.

Zeleke T, Kemal L, Mehari E, Sema F, Seid A, Mekonnen G Heliyon. 2024; 10(2):e24618.

PMID: 38298684 PMC: 10828699. DOI: 10.1016/j.heliyon.2024.e24618.


Antibiotics utilization patterns and dosage appropriateness among patients receiving hemodialysis.

Himali N, Al Suleimani Y, Al-Zakwani I, Abdelrahman A Saudi Pharm J. 2022; 30(7):971-978.

PMID: 35903523 PMC: 9315296. DOI: 10.1016/j.jsps.2022.05.005.


Prescription Practices in Patients With Mild to Moderate CKD in India.

Prasad N, Yadav A, Kundu M, Sethi J, Jaryal A, Sircar D Kidney Int Rep. 2021; 6(9):2455-2462.

PMID: 34514206 PMC: 8418981. DOI: 10.1016/j.ekir.2021.06.011.


The influence of cognitive-behavioral therapy on depression in dialysis patients - meta-analysis.

Zegarow P, Manczak M, Rysz J, Olszewski R Arch Med Sci. 2020; 16(6):1271-1278.

PMID: 33224325 PMC: 7667424. DOI: 10.5114/aoms.2019.88019.